QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:IKNX

IKONICS (IKNX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$26.61
$42.31
52-Week Range
N/A
Volume
1,394 shs
Average Volume
136,576 shs
Market Capitalization
$67.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IKNX stock logo

About IKONICS Stock (NASDAQ:IKNX)

IKONICS Corp. engages in the development, manufacture, and trade of photochemical imaging products. It operates through the following business segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). The Chromaline Segment sells screen printing film, emulsions, and inkjet receptive film primarily to distributors and some end users. The IKONICS Imaging segment develops and sells photo resistant film, art supplies, glass, metal medium, and abrasive etching equipment. The DTX segment includes patented inkjet technology used for mold texturing and prototyping. The AMS segment supplies sound deadening technology to the aerospace industry. The company was founded in 1952 and is headquartered in Duluth, MN.

IKNX Stock News Headlines

Ikonics reports earnings drop for 2013
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Ikonics to sell technology to Japanese auto industry
3 Stocks Pushing The Chemicals Industry Lower
SAATI and IKONICS Sign Definitive Acquisition Agreement
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
IKONICS Announces Third Quarter 2021 Results
IKONICS Announces Second Quarter 2021 Results
See More Headlines
Receive IKNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IKONICS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/25/2019
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Data Processing & Preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:IKNX
Employees
58
Year Founded
N/A

Profitability

Net Income
$-440,000.00
Pretax Margin
-2.48%

Debt

Sales & Book Value

Annual Sales
$13.43 million
Book Value
$5.99 per share

Miscellaneous

Free Float
1,689,000
Market Cap
$67.16 million
Optionable
Not Optionable
Beta
0.90
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Glenn Sandgren
    Chief Executive Officer & Director
  • Kenneth Hegman
    Chief Operating Officer
  • Jon R. Gerlach
    Chief Financial Officer, Secretary & VP-Finance
  • Claude P. Piguet
    Executive Vice President

IKNX Stock Analysis - Frequently Asked Questions

How were IKONICS's earnings last quarter?

IKONICS Co. (NASDAQ:IKNX) posted its quarterly earnings data on Thursday, April, 25th. The specialty chemicals company reported ($0.23) earnings per share (EPS) for the quarter. The specialty chemicals company had revenue of $3.53 million for the quarter. IKONICS had a positive trailing twelve-month return on equity of 11.27% and a negative net margin of 2.66%.

What is Bill Ulland's approval rating as IKONICS's CEO?

3 employees have rated IKONICS Chief Executive Officer Bill Ulland on Glassdoor.com. Bill Ulland has an approval rating of 37% among the company's employees. This puts Bill Ulland in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of IKONICS own?
This page (NASDAQ:IKNX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners